Share:
Share this content in WeChat
X
Experience Exchanges
Application of Care-bolus technique at different monitoring levels in displaying sub endometrial enhancement
YU Zeping  LÜ Furong  LÜ Fajin  XIAO Zhibo  XU Yong  Ma Juan 

Cite this article as: Yu ZP, Lü FR , Lü FJ, et al. Application of Care-bolus technique at different monitoring levels in displaying sub endometrial enhancement[J]. Chin J Magn Reson Imaging, 2022, 13(3): 76-78, 82. DOI:10.12015/issn.1674-8034.2022.03.015.


[Abstract] Objective To explore the application of Care-bolus technique at different monitoring levels in the display of sub endometrial enhancement.Materials and Methods Sixty-nine women were prospectively collected and randomly divided into group A and group B. Pelvis dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) was performed using Care-Bolus technique. The abdominal aorta in group A was monitored and the internal iliac artery in group B was monitored. After scanning, group A and group B were divided into groups A1、A2 and B1、B2 according to whether the uterus had lesions. The sub endometrial enhancement (SEE) display of each groups of data was evaluated and the display rate was calculated, and the signal intensity of SEE and adjacent normal muscular layers were measured. Chi-square test was used to qualitatively evaluate the SEE display rate of patients in each groups, and independent sample student test was used to quantitatively compare the differences of enhancement degree between SEE and the muscular layer in each groups.Results There was no significant difference in the display rate among all groups. SEE signal intensity was higher than that of the adjacent normal muscle layer, and the enhancement degree of group A was more obvious than that of group B, the difference was statistically significant (P<0.05). The degree of SEE and muscular enhancement in A2 group was more obvious than that in B2 group, and the difference was statistically significant (P<0.05).Conclusions The use of Care-bolus technique in DCE-MRI scan can well show the sub endometrial enhancement, and the monitoring of abdominal aorta is better than the internal iliac artery.
[Keywords] uterus;sub endometrial enhancement;Care-bolus technology;dynamic contrast enhanced;magnetic resonance imaging

YU Zeping   LÜ Furong*   LÜ Fajin   XIAO Zhibo   XU Yong   Ma Juan  

Lǚ FR, E-mail: lfr918@sina.com

Conflicts of interest   None.

Received  2021-08-31
Accepted  2022-03-07
DOI: 10.12015/issn.1674-8034.2022.03.015
Cite this article as: Yu ZP, Lü FR , Lü FJ, et al. Application of Care-bolus technique at different monitoring levels in displaying sub endometrial enhancement[J]. Chin J Magn Reson Imaging, 2022, 13(3): 76-78, 82.DOI:10.12015/issn.1674-8034.2022.03.015

[1]
Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2021[J]. CA Cancer J Clin, 2021, 71(1): 7-33. DOI: 10.3322/caac.21654.
[2]
Lin M, Zhang Q, Song Y, et al. Differentiation of endometrial adenocarcinoma from adenocarcinoma of cervix using kinetic parameters derived from DCE-MRI[J]. Eur J Radiol, 2020, 130: 109190. DOI: 10.1016/j.ejrad.2020.109190.
[3]
Cui TT, Shi F, Gu B, et al. Peritumoral enhancement for the evaluation of myometrial invasion in low-risk endometrial carcinoma on dynamic contrast-enhanced MRI[J]. Front Oncol, 2021, 11: 793709. DOI: 10.3389/fonc.2021.793709.
[4]
Bi Q, Bi GL, Wang JN, et al. Diagnostic accuracy of MRI for detecting cervical invasion in patients with endometrial carcinoma: a meta-analysis[J]. J Cancer, 2021, 12(3): 754-764. DOI: 10.7150/jca.52797.
[5]
Fujii S, Kido A, Baba T, et al. Subendometrial enhancement and peritumoral enhancement for assessing endometrial cancer on dynamic contrast enhanced MR imaging[J]. Eur J Radiol, 2015, 84(4): 581-589. DOI: 10.1016/j.ejrad.2015.01.004.
[6]
Lu KH, Broaddus RR. Endometrial cancer[J]. N Engl J Med, 2020, 383(21): 2053-2064. DOI: 10.1056/nejmra1514010.
[7]
Du LX, Li XH, Qiu XX, et al. Application of FLASH-3D dynamic contrast-enhanced imaging for diagnosis of endometrial carcinoma[J]. Br J Radiol, 2016, 89(1066): 20160268. DOI: 10.1259/bjr.20160268.
[8]
Zhang Z, Sun Z, Zhang KY, et al. The optimal application of Care bolus technique in acute venous sinus thrombosis[J]. Chin J Med Imaging, 2019, 29(1): 7-10.
[9]
Iyama Y, Nakaura T, Yokoyama K, et al. Comparison of the timing of hepatic arterial phase and image quality using test-bolus and bolus-tracking techniques in gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced hepatic dynamic magnetic resonance imaging[J]. J Comput Assist Tomogr, 2017, 41(4): 638-643. DOI: 10.1097/RCT.0000000000000583.
[10]
Boukobza M, Ilic-Habensus E, Duval X, et al. Usefulness of contrast-enhanced 3D MR angiography and contrast-enhanced 3D T1 sequence for detecting intracranial infectious aneurysms in infectious endocarditis[J]. Eur J Radiol, 2021, 144: 110008. DOI: 10.1016/j.ejrad.2021.110008.
[11]
Torre LA, Trabert B, DeSantis CE, et al. Ovarian cancer statistics, 2018[J]. CA Cancer J Clin, 2018, 68(4): 284-296. DOI: 10.3322/caac.21456.
[12]
Yang W, Wu Z, Yu M, et al. Characteristics of midluteal phase uterine artery hemodynamics in patients with recurrent pregnancy loss[J]. J Obstet Gynaecol Res, 2019, 45(7): 1230-1235. DOI: 10.1111/jog.13944.
[13]
Lacheta J. Uterine adenomyosis: pathogenesis, diagnostics, symptomatology and treatment[J]. Ceska Gynekol, 2019, 84(3): 240-246.
[14]
Ikhena DE, Bulun SE. Literature review on the role of uterine fibroids in endometrial function[J]. Reprod Sci, 2018, 25(5): 635-643. DOI: 10.1177/1933719117725827.
[15]
Dai YX, Feng FZ, Leng JH, et al. Imaging features and clinical analysis of diffuse uterine leiomyomatosis cases[J]. Chin Med J, 2020, 100(29): 2263-2267. DOI: 10.3760/cma.j.cn112137-20200307-00634.
[16]
Bi Q, Chen YH, Wu KH, et al. The diagnostic value of MRI for preoperative staging in patients with endometrial cancer: a meta-analysis[J]. Acad Radiol, 2020, 27(7): 960-968. DOI: 10.1016/j.acra.2019.09.018.
[17]
Bi Q, Chen YH, Chen J, et al. Predictive value of T2-weighted imaging and dynamic contrast-enhanced MRI for assessing cervical invasion in patients with endometrial cancer: a meta-analysis[J]. Clin Imaging, 2021, 78: 206-213. DOI: 10.1016/j.clinimag.2021.05.014.
[18]
Li XX, Lin TT, Liu B, et al. Diagnosis of cervical cancer with parametrial invasion on whole-tumor dynamic contrast-enhanced magnetic resonance imaging combined with whole-lesion texture analysis based on T2- weighted images[J]. Front Bioeng Biotechnol, 2020, 8: 590. DOI: 10.3389/fbioe.2020.00590.
[19]
Sun XX, Lan GB, Dai SL, et al. Diagnostic value of T2WI, DWI, DCE in detecting myometrial invasion of endometrial carcinoma[J]. Chin J Med Imaging, 2017, 27(7): 1338-1341.
[20]
Li B, Zhang L, Zhou DQ, et al. Application of Care bolus technique in Gd-EOB-DTPA enhanced liver dynamic MR imaging in HCC diagnosis[J]. Radiol Pract, 2014, 29(3): 330-333. DOI: 10.13609/j.cnki.1000-0313.2014.03.030.
[21]
Yu J, Lin SS, Lu H, et al. Optimize scan timing in abdominal multiphase CT: Bolus tracking with an individualized post-trigger delay[J]. Eur J Radiol, 2022, 148: 110139. DOI: 10.1016/j.ejrad.2021.110139.
[22]
Tsuboyama T, Jost G, Pietsch H, et al. Effect of gadoxetic acid injection duration on tumor enhancement in arterial phase liver MRI[J]. Acad Radiol, 2020, 27(8): e216-e223. DOI: 10.1016/j.acra.2019.10.018.
[23]
Löbe S, Leuthäusser C, Pölkow A, et al. Optimal timing of contrast-enhanced three-dimensional magnetic resonance left atrial angiography before pulmonary vein ablation[J]. Cardiol J, 2021, 28(4): 558-565. DOI: 10.5603/CJ.a2019.0112.
[24]
Zhang T, Yu JM, Wang YQ, et al. WHO grade I meningioma subtypes: MRI features and pathological analysis[J]. Life Sci, 2018, 213: 50-56. DOI: 10.1016/j.lfs.2018.08.061.
[25]
Wake N, Chandarana H, Rusinek H, et al. Accuracy and precision of quantitative DCE-MRI parameters: how should one estimate contrast concentration?[J]. Magn Reson Imaging, 2018, 52: 16-23. DOI: 10.1016/j.mri.2018.05.007.

PREV Study on the correlation between APT and mDixon-Quant in the right renal cortex and medulla of patients with chronic kidney disease
NEXT Utility of delta ADC value to differentiate uterine carcinosarcoma from endometrial carcinomas
  



Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn